RNAi inhibitor for inhibiting expression of angiotensinogen gene and application of RNAi inhibitor

The invention relates to siRNA (small interfering Ribonucleic Acid) for inhibiting the expression of angiotensinogen (AGT), which comprises a positive-sense strand and an antisense strand, and the sequence of the positive-sense strand is shown as AGCCACAGAGUCUACCCAAU; and the sequence of the antisen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GAO MINGZHANG, MA YARU, MO ZHENXIAN, WANG BINJIE, ZHOU MINHUA, LIU XINJIAN, FAN FUSHUN, QIAN CHANGGENG, LIU HAIQI
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator GAO MINGZHANG
MA YARU
MO ZHENXIAN
WANG BINJIE
ZHOU MINHUA
LIU XINJIAN
FAN FUSHUN
QIAN CHANGGENG
LIU HAIQI
description The invention relates to siRNA (small interfering Ribonucleic Acid) for inhibiting the expression of angiotensinogen (AGT), which comprises a positive-sense strand and an antisense strand, and the sequence of the positive-sense strand is shown as AGCCACAGAGUCUACCCAAU; and the sequence of the antisense strand is as shown in AUUGGGUAGACUCUGUGGGCUCU. The invention also provides a modified siRNA (small interfering Ribonucleic Acid) used for inhibiting the expression of angiotensin (AGT), the sequence of the positive-sense strand is shown as mAsmGsmCmCmCmAfCmAmGfGmUfCmCmCmAmAmU, the sequence of the antisense strand is shown as The siRNA and the proper modification sequence thereof disclosed by the invention have good in-vitro and in-vivo biological activity, and are expected to be clinically applied to hypertension treatment. 本发明涉及一种用于抑制血管紧张素原(AGT)表达的siRNA,包括正义链及反义链,所述正义链序列如AGCCCACAGAGUCUACCCAAU所示;所述反义链序列如AUUGGGUAGACUCUGUGGGCUCU所示。还提供了一种经过了修饰的、用于抑制血管紧张素原(AGT)表达的siRNA,所述正义链序列如mAsmGsmCmCmCmAfCmAdGfAfGmUfCmUmAmCmCmCm
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN117264948A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN117264948A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN117264948A3</originalsourceid><addsrcrecordid>eNrjZEgK8nPMVMjMy8hMyizJL1JIA2IoLzMvXSG1oqAotbg4Mz9PIT9NITEvPTO_JDWvODMvPz01TwGIU4GCKQqJBQU5mcmJJVB1qGbyMLCmJeYUp_JCaW4GRTfXEGcP3dSC_PjU4oLEZKAxJfHOfoaG5kZmJpYmFo7GxKgBAE70PhU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>RNAi inhibitor for inhibiting expression of angiotensinogen gene and application of RNAi inhibitor</title><source>esp@cenet</source><creator>GAO MINGZHANG ; MA YARU ; MO ZHENXIAN ; WANG BINJIE ; ZHOU MINHUA ; LIU XINJIAN ; FAN FUSHUN ; QIAN CHANGGENG ; LIU HAIQI</creator><creatorcontrib>GAO MINGZHANG ; MA YARU ; MO ZHENXIAN ; WANG BINJIE ; ZHOU MINHUA ; LIU XINJIAN ; FAN FUSHUN ; QIAN CHANGGENG ; LIU HAIQI</creatorcontrib><description>The invention relates to siRNA (small interfering Ribonucleic Acid) for inhibiting the expression of angiotensinogen (AGT), which comprises a positive-sense strand and an antisense strand, and the sequence of the positive-sense strand is shown as AGCCACAGAGUCUACCCAAU; and the sequence of the antisense strand is as shown in AUUGGGUAGACUCUGUGGGCUCU. The invention also provides a modified siRNA (small interfering Ribonucleic Acid) used for inhibiting the expression of angiotensin (AGT), the sequence of the positive-sense strand is shown as mAsmGsmCmCmCmAfCmAmGfGmUfCmCmCmAmAmU, the sequence of the antisense strand is shown as The siRNA and the proper modification sequence thereof disclosed by the invention have good in-vitro and in-vivo biological activity, and are expected to be clinically applied to hypertension treatment. 本发明涉及一种用于抑制血管紧张素原(AGT)表达的siRNA,包括正义链及反义链,所述正义链序列如AGCCCACAGAGUCUACCCAAU所示;所述反义链序列如AUUGGGUAGACUCUGUGGGCUCU所示。还提供了一种经过了修饰的、用于抑制血管紧张素原(AGT)表达的siRNA,所述正义链序列如mAsmGsmCmCmCmAfCmAdGfAfGmUfCmUmAmCmCmCm</description><language>chi ; eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20231222&amp;DB=EPODOC&amp;CC=CN&amp;NR=117264948A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25568,76551</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20231222&amp;DB=EPODOC&amp;CC=CN&amp;NR=117264948A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GAO MINGZHANG</creatorcontrib><creatorcontrib>MA YARU</creatorcontrib><creatorcontrib>MO ZHENXIAN</creatorcontrib><creatorcontrib>WANG BINJIE</creatorcontrib><creatorcontrib>ZHOU MINHUA</creatorcontrib><creatorcontrib>LIU XINJIAN</creatorcontrib><creatorcontrib>FAN FUSHUN</creatorcontrib><creatorcontrib>QIAN CHANGGENG</creatorcontrib><creatorcontrib>LIU HAIQI</creatorcontrib><title>RNAi inhibitor for inhibiting expression of angiotensinogen gene and application of RNAi inhibitor</title><description>The invention relates to siRNA (small interfering Ribonucleic Acid) for inhibiting the expression of angiotensinogen (AGT), which comprises a positive-sense strand and an antisense strand, and the sequence of the positive-sense strand is shown as AGCCACAGAGUCUACCCAAU; and the sequence of the antisense strand is as shown in AUUGGGUAGACUCUGUGGGCUCU. The invention also provides a modified siRNA (small interfering Ribonucleic Acid) used for inhibiting the expression of angiotensin (AGT), the sequence of the positive-sense strand is shown as mAsmGsmCmCmCmAfCmAmGfGmUfCmCmCmAmAmU, the sequence of the antisense strand is shown as The siRNA and the proper modification sequence thereof disclosed by the invention have good in-vitro and in-vivo biological activity, and are expected to be clinically applied to hypertension treatment. 本发明涉及一种用于抑制血管紧张素原(AGT)表达的siRNA,包括正义链及反义链,所述正义链序列如AGCCCACAGAGUCUACCCAAU所示;所述反义链序列如AUUGGGUAGACUCUGUGGGCUCU所示。还提供了一种经过了修饰的、用于抑制血管紧张素原(AGT)表达的siRNA,所述正义链序列如mAsmGsmCmCmCmAfCmAdGfAfGmUfCmUmAmCmCmCm</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZEgK8nPMVMjMy8hMyizJL1JIA2IoLzMvXSG1oqAotbg4Mz9PIT9NITEvPTO_JDWvODMvPz01TwGIU4GCKQqJBQU5mcmJJVB1qGbyMLCmJeYUp_JCaW4GRTfXEGcP3dSC_PjU4oLEZKAxJfHOfoaG5kZmJpYmFo7GxKgBAE70PhU</recordid><startdate>20231222</startdate><enddate>20231222</enddate><creator>GAO MINGZHANG</creator><creator>MA YARU</creator><creator>MO ZHENXIAN</creator><creator>WANG BINJIE</creator><creator>ZHOU MINHUA</creator><creator>LIU XINJIAN</creator><creator>FAN FUSHUN</creator><creator>QIAN CHANGGENG</creator><creator>LIU HAIQI</creator><scope>EVB</scope></search><sort><creationdate>20231222</creationdate><title>RNAi inhibitor for inhibiting expression of angiotensinogen gene and application of RNAi inhibitor</title><author>GAO MINGZHANG ; MA YARU ; MO ZHENXIAN ; WANG BINJIE ; ZHOU MINHUA ; LIU XINJIAN ; FAN FUSHUN ; QIAN CHANGGENG ; LIU HAIQI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN117264948A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2023</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>GAO MINGZHANG</creatorcontrib><creatorcontrib>MA YARU</creatorcontrib><creatorcontrib>MO ZHENXIAN</creatorcontrib><creatorcontrib>WANG BINJIE</creatorcontrib><creatorcontrib>ZHOU MINHUA</creatorcontrib><creatorcontrib>LIU XINJIAN</creatorcontrib><creatorcontrib>FAN FUSHUN</creatorcontrib><creatorcontrib>QIAN CHANGGENG</creatorcontrib><creatorcontrib>LIU HAIQI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GAO MINGZHANG</au><au>MA YARU</au><au>MO ZHENXIAN</au><au>WANG BINJIE</au><au>ZHOU MINHUA</au><au>LIU XINJIAN</au><au>FAN FUSHUN</au><au>QIAN CHANGGENG</au><au>LIU HAIQI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>RNAi inhibitor for inhibiting expression of angiotensinogen gene and application of RNAi inhibitor</title><date>2023-12-22</date><risdate>2023</risdate><abstract>The invention relates to siRNA (small interfering Ribonucleic Acid) for inhibiting the expression of angiotensinogen (AGT), which comprises a positive-sense strand and an antisense strand, and the sequence of the positive-sense strand is shown as AGCCACAGAGUCUACCCAAU; and the sequence of the antisense strand is as shown in AUUGGGUAGACUCUGUGGGCUCU. The invention also provides a modified siRNA (small interfering Ribonucleic Acid) used for inhibiting the expression of angiotensin (AGT), the sequence of the positive-sense strand is shown as mAsmGsmCmCmCmAfCmAmGfGmUfCmCmCmAmAmU, the sequence of the antisense strand is shown as The siRNA and the proper modification sequence thereof disclosed by the invention have good in-vitro and in-vivo biological activity, and are expected to be clinically applied to hypertension treatment. 本发明涉及一种用于抑制血管紧张素原(AGT)表达的siRNA,包括正义链及反义链,所述正义链序列如AGCCCACAGAGUCUACCCAAU所示;所述反义链序列如AUUGGGUAGACUCUGUGGGCUCU所示。还提供了一种经过了修饰的、用于抑制血管紧张素原(AGT)表达的siRNA,所述正义链序列如mAsmGsmCmCmCmAfCmAdGfAfGmUfCmUmAmCmCmCm</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN117264948A
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
title RNAi inhibitor for inhibiting expression of angiotensinogen gene and application of RNAi inhibitor
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T01%3A52%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GAO%20MINGZHANG&rft.date=2023-12-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN117264948A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true